SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.850
-0.170 (-3.39%)
At close: Dec 5, 2025, 4:00 PM EST
4.940
+0.090 (1.86%)
After-hours: Dec 5, 2025, 7:39 PM EST
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $329.06 million as of December 5, 2025. Its market cap has increased by 50.09% in one year.
Market Cap
329.06M
Enterprise Value
310.82M
1-Year Change
50.09%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $329.06M, a decrease of -70.63%. That is a compound annual growth rate of -24.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 340.59M | 66.98% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.21B |
| Johnson & Johnson | 486.92B |
| AbbVie | 403.28B |
| UnitedHealth Group | 300.78B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 251.35B |
| Abbott Laboratories | 216.45B |